🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Mérida
Clinical trial register · Spain

Clinical Trials in Mérida, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5885 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:52 UTC
5885
Studies in scope
all four open statuses
3103
Recruiting now
open to new participants
1139
Lead sponsors
across recruiting studies
Top sites
Barcelona 3233 Madrid 3015 Valencia 1201 Seville 1055 Málaga 741
Narrow the registerReset
Recruitment status
Phase
Site location
Barcelona3233 Madrid3015 Valencia1201 Seville1055 Málaga741
All 455 locations
Target enrolment
to

Trials with a site in Mérida

18 of 5885 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
NCT07088926Bronchiectasis With Pseudomonas Aeruginosa Colonization
AstraZeneca
Phase 2
435
Barcelona, Benalmádena, Madrid, Mérida, Patraix, Valencia
2025-11-06
Recruiting
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
NCT07175285Systemic Lupus Erythematosus (SLE)
Bristol-Myers Squibb
Observational
223
Mérida, Barcelona
2025-10-08
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
NCT07190209Chronic Obstructive Pulmonary Disease
Sanofi
Phase 3
942
Mérida, L'Hospitalet de Llobregat, Jerez de la Frontera, Benalmádena, Cáceres, Málaga, Palma, Seville
2025-09-16
Active, closed
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
NCT06979531Primary Sjögren's Syndrome
Immunovant Sciences GmbH
Phase 2
180
Bilbao, Cadiz, Córdoba, Mérida, Valencia
2025-06-30
Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
NCT07082738Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca
Phase 2
987
Benalmádena, Granollers, Madrid, Málaga, Mérida, Pozuelo de Alarcón, Santander
2025-06-27
Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
NCT06916806Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies, Rheumatoid Arthritis
AstraZeneca
Phase 1
72
Mérida, Seville, Valladolid
2025-05-01
Recruiting
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
NCT06932263Asthma
AstraZeneca
Phase 2
540
Barcelona, Madrid, Málaga, Mérida, Patraix, Santander
2025-03-26
Recruiting
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
NCT06671483Psoriatic Arthritis
Takeda
Phase 3
1,088
Mérida, Sabadell, Santiago de Compostela, Málaga, Seville, Valencia
2025-03-03
Recruiting
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
NCT06617325Systemic Lupus Erythematosus
UCB Biopharma SRL
Phase 3
450
A Coruña, Badajoz, Barcelona, Castellon, Madrid, Málaga, Mérida, Sabadell
2024-11-21
Active, closed
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome
NCT05946941Sjögren's Syndrome
Bristol-Myers Squibb
Phase 3
774
Mérida, Santander, San Cristóbal de La Laguna, A Coruña, Santiago de Compostela, Seville
2023-09-11
Active, closed
Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine
NCT05846230Bronchiectasis
Boehringer Ingelheim
Phase 2
268
Barcelona, L'Hospitalet de Llobregat, Mérida, Pozuelo de Alarcón
2023-09-08
Active, closed
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
NCT05878769Chronic Obstructive Pulmonary Disease
Hoffmann-La Roche
Phase 3
2,000
Mérida, Palma de Mallorca, Santander, Santiago de Compostela, Torrejón de Ardoz, Benalmádena Costa, Alzira, Barcelona
2023-06-28
Active, closed
A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus
NCT05620407Systemic Lupus Erythematosus
Bristol-Myers Squibb
Phase 3
513
Mérida, Barcelona, Bilbao, Santander, Cordoba, Seville, Valencia, Valladolid
2023-01-12
Recruiting
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma
NCT05222529Asthma
Novartis Pharmaceuticals
Phase 2
42
Esplugues, Sabadell, Mérida, Barcelona
2022-08-29
Recruiting
Spanish Registry of Patients With IgM Monoclonal Gammopathies
NCT05093153Waldenstrom Macroglobulinemia
Fundación Española de Hematología y Hemoterapía
Observational
1,000
Mérida, Palma, Palma de Mallorca, Badalona, Barcelona, Manresa, Sabadell, Córdoba
2021-10-01
Recruiting
The EpiGASTRIC/EDGAR Project: New Strategies for the Early Detection and Prevention of Gastric Cancer
NCT05551416Gastric Neoplasms, Gastric Cancer, Gastric Lesion
EDUARDO ALBENIZ
Observational
1,200
Palma de Mallorca, Porto Cristo, Granollers, Terrassa, Aranda de Duero, Mérida, Ourense, Majadahonda
2021-09-09
Active, closed
Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis
NCT04871919Rheumatoid Arthritis
Alfasigma S.p.A.
Observational
1,304
A Coruña, Barcelona, Córdoba, Mérida, Murcia, Palma, Pontevedra, Santa Cruz de Tenerife
2021-05-11
Active, closed
Incremental Haemodialysis in Incident Patients
NCT03239808Renal Disease, End-Stage
Fundación para la Formación e Investigación de los Profesionales de la Salud de Extremadura
Not applicable
152
Mérida, Plasencia, Cáceres
2018-03-14
Rows per page Showing 1–18 of 18
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-spain/city/m-rida

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,885 studies in total at the last sync on 26 Sep 2026, 19:52 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 18 of those studies with a site in Mérida.

How many clinical trials are recruiting in Mérida?

11 of the 18 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:52 UTC sync. A further 0 have not yet opened recruitment, 7 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Mérida), 18 studies
PhaseStudiesRecruitingShare
Phase 26433.3%
Phase 36333.3%
Observational4322.2%
Not applicable105.6%
Phase 1115.6%

Most active sponsors

Lead sponsors with the most studies (Mérida)
Lead sponsorStudiesRecruiting
AstraZeneca44
Bristol-Myers Squibb31
Alfasigma S.p.A.10
Boehringer Ingelheim10
EDUARDO ALBENIZ11
Fundación Española de Hematología y Hemoterapía11
Fundación para la Formación e Investigación de los Profesionales de la Salud de Extremadura10
Hoffmann-La Roche10
Immunovant Sciences GmbH10
Novartis Pharmaceuticals11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.